Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | RELA | Q04206 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10165321 | 0.91 | ALDH1A1 (0.41) | ALDH1A1TSHR | |
| SCHEMBL2681787 | 0.84 | ALDH1A1 (0.39) | ALDH1A1TSHRMAPTKDM4ECYP1A2 | |
| SCHEMBL12114947 | 0.80 | ALDH1A1 (0.59) | ALDH1A1TSHRMAPTKDM4ECYP1A2 | |
| SCHEMBL172194 | 0.80 | ALDH1A1 (0.59) | ALDH1A1TSHRMAPTKDM4ECYP1A2 | |
| SCHEMBL99027 | 0.80 | ALDH1A1 (0.59) | ALDH1A1TSHRMAPTKDM4ECYP1A2 | |
| SCHEMBL1177035 | 0.80 | ALDH1A1 (0.59) | ALDH1A1TSHRMAPTKDM4ECYP1A2 | |
| SCHEMBL20386511 | 0.80 | ALDH1A1 (0.39) | ALDH1A1TSHRMAPTKDM4ECYP1A2 | |
| SCHEMBL9551640 | 0.78 | ALDH1A1 (0.35) | ALDH1A1MAPTKDM4ECYP1A2CYP3A4 | |
| SCHEMBL10165323 | 0.78 | DPP4 (0.37) | ALDH1A1TSHRMAPTKDM4EL3MBTL1 | |
| SCHEMBL17012389 | 0.75 | NOTUM (0.37) | ALDH1A1TSHRMAPTKDM4ECYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8338691-B2 | Photoelectric conversion element and imaging device | FUJIFILM CORPORATION (JP) | 2012-12-25 | — | — | US | disclosed |
| US-8258506-B2 | Photoelectric conversion device, production method thereof and imaging device | FUJIFILM CORPORATION (JP) | 2012-09-04 | — | — | US | disclosed |
| US-20120080585-A1 | PHOTOELECTRIC CONVERSION ELEMENT, PRODUCTION METHOD THEREOF, PHOTOSENSOR, IMAGING DEVICE AND THEIR DRIVING METHOD | FUJIFILM CORPORATION (JP) | 2012-04-05 | — | — | US | disclosed |
| US-20100308311-A1 | PHOTOELECTRIC CONVERSION DEVICE AND IMAGING DEVICE | FUJIFILM CORPORATION (JP) | 2010-12-09 | — | — | US | disclosed |
| US-20100308312-A1 | PHOTOELECTRIC CONVERSION DEVICE, PRODUCTION METHOD THEREOF AND IMAGING DEVICE | FUJIFILM CORPORATION (JP) | 2010-12-09 | — | — | US | disclosed |
| US-20090223566-A1 | PHOTOELECTRIC CONVERSION ELEMENT AND IMAGING DEVICE | FUJIFILM CORPORATION (JP) | 2009-09-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120080585-A1 | PHOTOELECTRIC CONVERSION ELEMENT, PRODUCTION METHOD THEREOF, PHOTOSENSOR, IMAGING DEVICE AND THEIR DRIVING METHOD | SUN2, CYBA, PPOX | ALDH1A1 1609/4885TSHR 3845/4885MAPT 342/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.